✦ LIBER ✦

Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease

✍ Scribed by Williams, Kirsten M.; Pavletic, Steven Z.; Lee, Stephanie J.; Cottle-Delisle, Candice; Hakim, Fran; Manning-Geiss, Beryl; Mitchell, Sandra; Gea-Banacloche, Juan; Comis, Leora; Cowen, Edward W.; Baird, Kristin; Shelhamer, James H.; Fowler, Daniel; Blacklock-Schuver, Bazetta A.J.; Avila, Daniele; Gress, Ronald

Book ID: 122327578
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.11.087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary Results Of A Phase II Trial

Preliminary Results Of A Phase II Trial Of Montelukast For The Treatment Of Bronchiolitis Obliterans Syndrome After HSCT

✍ K.M. Williams; S.Z. Pavletic; F.T. Hakim; S.A. Mitchell; J.C. Gea-Banacloche; L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Preliminary Results of a Phase II Trial

Preliminary Results of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT

✍ K.M. Williams; S.Z. Pavletic; F.T. Hakim; S.A. Mitchell; J.C. Gea-Banacloche; L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Interim Analysis of a Phase II Trial to

Interim Analysis of a Phase II Trial to Examine Use of Postchemotherapy Volumes After Neo-adjuvant Treatment of Squamous Cell Carcinomas of the Head and Neck

✍ Caudell, J.J.; Ma, J.; Jennelle, R.; Hamilton, R.D.; Pitman, K.; Otto, K.; Jeffe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 87 KB

An interim analysis of a phase II/III pr

An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the hepatassist® bioartificial liver support system for the treatment of fulminant hepatic failure: Anthony C Stevens, Circe Biomed, Lexington, MA; R Busuttil, S Han, A Baquerizo, UCLA, Los Angeles, CA; J Fair, R Shrestha, M Johnson, UNC Sch of Medicine, Chapel Hill, NC; J Bloomer, B McGuire, Univ of Alabama, Birmingham, AL; P Rosenthal, N Ascher, C Freise, UCSF, San Francisco, CA; F Watanabe, Cedars Sinai Medical Ctr, Los Angeles, CA; X Rogiers, J Schulte am Esch, Univ Krankenhauf Eppendorf, Hamburg Germany; S Nyberg, R H Wiesner, Mayo Clinic, Rochester, MN; C Broelsch, M Malago, Universitatsklinikum Essen, Essen Germany; A Kribben, J Lerut, Cliniques Universitaires St Luc, Brussels Brussels Belgium; P Laterre, Cliniques Universitaires St Luc, Brussels Belgium; M Salizzoni, B Lavezzo, San Giovanni Battista di Torino, Turin Italy; R Brown, J Emond, S Lobritto, New York Presbyterian Hosp, New York, NY; B de Hemptinne, F Colardyn, E Hoste, Universitair Zeikenhaus Ghent, Ghent Belgium; E Fagan, Rush Presbyterian, Chicago, IL; L McChesney, Univ of Toledo, Toledo, OH; M Muraca, Univ di Padova, Padova Italy; A Mas Ordeig, J Salmeron, Hosp Clinic Provincial de Barcelona, Barcelona Spain; J Rabkin, Oregon Health Sciences Univ, Portland, OR; D Pratt, New England Medical Ctr, Boston, MA; M de la Mata, J Montero, J Pozo, Hosp Reina Sofia, Cordova Spain; H Metselaar, Univ Hosp Rotterdam, Rotterdam, The Netherlands, Rotterdam Netherlands; G Everson, Univ of Colorado, Denver, CO; Z Pitkin, C Mullon, B Solomon, Circe Biomed, Lexington, MA; A Demetriou, Cedars Sinai Medical Ctr, Los Angeles, CA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB